22nd Century Group Inc (OQ:XXII)

May 08, 2024 09:18 am ET
22nd Century Group to Participate in the Aegis Capital Virtual Conference on May 9, 2024
Mocksville, North Carolina--(Newsfile Corp. - May 8, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it will present at the Aegis Capital Virtual Conference on Thursday, May 9, 2024 at 2:30 PM Eastern Time.
May 07, 2024 08:15 am ET
22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024
Mocksville, North Carolina--(Newsfile Corp. - May 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve health and wellness, will host a live webcast on Wednesday, May 15, 2024, at 8:00 AM ET to discuss its 2024 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
Apr 30, 2024 09:00 am ET
22nd Century Eliminates $5.2 Million of Debt in Above-Market Equity Transaction
Improves Balance Sheet, Eliminates Future Omnia Interest Expense and Increases Shareholder Equity
Apr 18, 2024 05:00 pm ET
Apr 18, 2024 09:00 am ET
22nd Century Group Regains Compliance with NASDAQ Minimum Bid Price Rule
Continues Focus on Growing Sales with New Contracts, Progress Toward Cash Positive Operations
Apr 15, 2024 09:00 am ET
22nd Century Group to Participate in the Planet MicroCap Showcase on May 1-2, 2024
Mocksville, North Carolina--(Newsfile Corp. - April 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it will present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 3:30 PM Pacific Time.
Apr 11, 2024 04:45 pm ET
22nd Century Group Expands CMO Business with New Pinnacle Brand Cigarillo Products
Pinnacle Branded Products Growing At Over 10% at Top-5 U.S. C-Store Chain
Apr 08, 2024 09:25 am ET
22nd Century Announces Plan to Eliminate Its Senior Secured Debt
Company Bolsters Balance Sheet with $4.2 Million Capital Infusion
Apr 04, 2024 05:48 pm ET
22nd Century Group (XXII) Signs Large New CMO Customer
New Contract Will Commence in Second Quarter, Ultimately Boost CMO Volumes by More Than 20%
Mar 28, 2024 06:00 am ET
22nd Century Group (XXII) Reports Fourth Quarter 2023 Financial Results
Mocksville, North Carolina--(Newsfile Corp. - March 28, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today reported results for the fourth quarter ended December 31, 2023, and provided an update on recent business highlights.
Mar 15, 2024 08:00 am ET
22nd Century Group to Announce Fourth Quarter 2023 Results on March 28, 2024
Mocksville, North Carolina--(Newsfile Corp. - March 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve smoker health and wellness, will host a live webcast on Thursday, March 28, 2024, at 8:00 AM ET to discuss its 2023 fourth quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
Feb 13, 2024 04:15 pm ET
22nd Century Group Announces Reduction in Board Compensation
Reduced Cost Structure Expected to Save more than $1Million Annually in 2024, Aligns Board with Corporate-Wide Lean Operating Commitment
Feb 07, 2024 07:00 am ET
Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now
EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 67th Emerging Growth Conference on February 7 & 8, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with...
Feb 06, 2024 11:00 am ET
22nd Century Group to Present at the Emerging Growth Conference on February 8, 2024
Mocksville, North Carolina--(Newsfile Corp. - February 6, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced that the Company will present at the Emerging Growth Conference on February 8, 2024.
Jan 24, 2024 04:15 pm ET
22nd Century Group Announces Partial Adjournment of Annual Meeting for Proposal 2, All Other Proposals Passed
Transforming Business into Lean Operating Base, Extending Cash Runway, Shareholder Meeting to Re-convene February 15
Jan 17, 2024 08:45 am ET
Jan 12, 2024 08:31 am ET
Thinking about buying stock in Aeries Technology, 22nd Century Group, Elevation Oncology, Rivian Automotive, or Safe & Green Development?
NEW YORK, Jan. 12, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AERT, XXII, ELEV, RIVN, and SGD.
Jan 12, 2024 08:30 am ET
22nd Century Group to Host Fireside Chat Event on January 17
Analyst Hosted Event to Discuss Refocused Business, Cost Reductions and Turnaround Plan
Dec 28, 2023 04:20 pm ET
22nd Century Group Completes Sale of Hemp/Cannabis Franchise
Sale Will Significantly Reduce Operating Expenses, Ultimately Reduce Debt by $5.2 Million
Dec 14, 2023 04:05 pm ET
22nd Century Group's Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms
Sale and Related Actions Ultimately Expected to Reduce Debt Principal by $5.2 Million
Dec 04, 2023 07:07 am ET
22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction
22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the exercise of warrants by certain holders pursuant to its previously...
Nov 29, 2023 07:07 am ET
22nd Century Appoints Larry Firestone as Chairman and CEO
22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the appointment of Lawrence (Larry) Firestone as the...
Nov 27, 2023 04:44 pm ET
22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise
22nd Century Group, Inc. (Nasdaq: XXII) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has reached an agreement to sell...
Nov 08, 2023 01:15 pm ET
22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced that it has again...
Nov 07, 2023 08:45 am ET
22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis, and hops, today announced the signing of an...
Nov 06, 2023 07:30 am ET
22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today reported results for the third...
Oct 26, 2023 08:30 am ET
22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, announced that it supports the recent...
Oct 25, 2023 09:00 am ET
22nd Century Group (XXII) Reduces Debt by $8.1 Million
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, announced that it has reduced the...
Oct 17, 2023 09:15 am ET
22nd Century Announces Pricing of $5.25 Million Public Offering
22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced the pricing of its previously...
Oct 16, 2023 04:05 pm ET
22nd Century Announces Proposed Public Offering
22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it intends to offer and...
Sep 12, 2023 07:00 am ET
22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced its FDA authorized VLN®...
Sep 05, 2023 07:00 am ET
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
22nd Century Group, Inc. (NASDAQ: XXII) (the “Company”) today announced that its Board of Directors, after consultation with its financial and legal advisors, has initiated a process to evaluate strategic alternatives with respect to the Company’s...
Sep 05, 2023 07:00 am ET
Presenting on the Emerging Growth Conference on September 6 and 7 Register Now
EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 62nd Emerging Growth Conference on September 6 & 7, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with...
Aug 14, 2023 06:00 am ET
22nd Century Group (XXII) Reports Second Quarter 2023 Financial Results
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today reported results for the Second...
Aug 09, 2023 08:00 am ET
22nd Century Group (XXII) Updates Second Quarter 2023 Results Webcast Time on August 14, 2023
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Monday, August 14, 2023, at a...
Aug 08, 2023 07:00 am ET
Presenting on the Emerging Growth Conference on August 9 & 10 Register Now
EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 60th Emerging Growth Conference on August 9, 10, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong...
Aug 07, 2023 08:00 am ET
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2023 Results on August 14, 2023
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Monday, August 14, 2023, at 10:00...
Aug 02, 2023 05:12 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of 22nd Century Group, Inc. – XXII
Pomerantz LLP is investigating claims on behalf of investors of 22nd Century Group, Inc. (“22nd Century” or the “Company”) (NASDAQ: XXII). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Aug 02, 2023 09:31 am ET
Thinking about buying stock in Innoviz Technologies, 22nd Century Group, SmileDirectClub, Checkpoint Therapeutics, or View, Inc.?
NEW YORK, Aug. 2, 2023 /PRNewswire/ --InvestorsObserver issues critical PriceWatch Alerts for INVZ, XXII, SDC, CKPT, and VIEW.
Jul 26, 2023 02:05 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 22nd Century Group, Inc. - XXII
NEW YORK, July 26, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of 22nd Century Group, Inc. ("22nd Century" or the "Company") (NASDAQ: XXII).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jul 24, 2023 10:47 am ET
New to The Street TV Announces Episode 491 with its Five Business Guest Interviews, Airs on FOX Business Network, Tonight, July 24, 2023, at 10:30 PM PT
FMW Media's New to The Street announces broadcasting of its business show that will air on the FOX Business Network, tonight, July 24, 2023, at 10:30 PM PT. New to The Street's TV episode 491 will air the following five (5) business interviews:...
Jul 24, 2023 09:20 am ET
22nd Century Announces Executive Leadership Changes
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, announced today that John Miller, who leads the tobacco...
Jul 20, 2023 09:20 am ET
22nd Century Group (XXII) Regains Compliance with Nasdaq Listing Standards
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced notification that it has...
Jul 17, 2023 09:20 am ET
A Cigarette to Help Californians Smoke Less: 22nd Century Group, Inc. Launches Reduced Nicotine VLN® King Cigarettes in California, VLN Will Be Sold at #1 U.S. Convenience Store Chain and Other Respon
Biotech company 22nd Century Group, Inc. (NASDAQ: XXII) this week launched VLN® King cigarettes, the first-ever reduced nicotine combustible cigarette, in the California market. Starting July 17th, VLN® cigarettes contain a staggering 95% less...
Jul 13, 2023 09:40 am ET
New to The Street TV Announces Episode 488 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Tonight, July 13, 2023, at 9:30 PM PT
FMW Media's New to The Street announces broadcasting of its business show that will air as a sponsored program on Bloomberg TV tonight, Thursday, July 13, 2023, at 9:30 PM PT. New to The Street's TV episode 488 will air the following five (5)...
Jul 13, 2023 08:40 am ET
22nd Century Group (XXII) VLN® Products Now Selling in Montana C-Stores
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced its VLN® reduced...
Jul 12, 2023 08:35 am ET
22nd Century Group (XXII) Announces New Agreement with Hub, Inc. to Expand Midwest Distribution
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today announced a new distribution...
Jul 07, 2023 09:31 am ET
Thinking about buying stock in Gorilla Technology Group, Arrival, 22nd Century Group, Greenidge Generation, or Abacus Life?
NEW YORK, July 7, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GRRR, ARVL, XXII, GREE, and ABL.
Jul 06, 2023 09:25 am ET
22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it has entered into definitive agreements...
Jul 03, 2023 06:00 am ET
22nd Century Announces 1-for-15 Reverse Stock Split
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it will effect a reverse stock split of...
Jun 23, 2023 09:00 am ET
22nd Century Group (XXII) Announces Production of VLN® Homogenized Tobacco Leaf Sheet
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced it has successfully produced homogenized...
Jun 21, 2023 09:00 am ET
VLN® Products Launch in Nevada to Help Smokers Smoke Less
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced its FDA authorized VLN® reduced nicotine...
Jun 20, 2023 07:00 am ET
22nd Century Announces $5.3 Million Registered Direct Offering Priced Above Market
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it has entered into definitive agreements...
Jun 06, 2023 09:00 am ET
22nd Century Group (XXII) Launching VLN® at #1 U.S. C-Store Chain in Texas, California and Florida
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that its VLN® reduced nicotine content...
Jun 02, 2023 08:30 am ET
22nd Century Group (XXII) Announces Participation in the LD Micro Invitational XIII
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced it will participate in the 13th Annual LD...
May 25, 2023 09:00 am ET
22nd Century Group (XXII) Highlights Recent TCORS Symposium Findings
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today provided comments following the recent Tobacco Centers...
May 09, 2023 06:00 am ET
22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today reported results for the first...
May 03, 2023 09:15 am ET
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2023 Results on May 9, 2023
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Tuesday, May 9, 2023, at 10:00 AM...
May 02, 2023 09:15 am ET
22nd Century Group (XXII) Announces Strategic License, Manufacturing and Distribution Agreement with Old Pal
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced its second exclusive license, manufacturing...
Apr 18, 2023 07:00 am ET
22nd Century Group Launches New Private Label Brand with Top U.S. C-Store Chain
Pinnacle Cigarette Brand to Be Sold in up to 1,700 U.S. Retail Locations in up to 27 States
Apr 05, 2023 08:30 am ET
22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced a new three-year exclusive license and...
Mar 09, 2023 06:00 am ET
22nd Century Group (Nasdaq: XXII) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today reported results for the fourth quarter and full year...
Mar 03, 2023 04:05 pm ET
22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives
22nd Century Group, Inc. (Nasdaq: XXII), the world’s leading biotechnology company dedicated to improving health with reduced nicotine tobacco and advanced plant technologies in both hemp/cannabis and hops, today announced a new $21 million senior...
Mar 02, 2023 04:15 pm ET
22nd Century Group (Nasdaq: XXII) to Participate in March 2023 Roth Investor Conference
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that the Company will be participating in...
Feb 23, 2023 09:00 am ET
22nd Century Group (Nasdaq: XXII) to Announce Fourth Quarter and Full Year 2022 Results on March 9, 2023
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Thursday, March 9, 2023, at 10:00...
Feb 22, 2023 09:00 am ET
22nd Century Group (XXII) Accelerates Major Growing Program to Enable Implementation of New Zealand’s Reduced-Nicotine Content Tobacco Law
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced it has accelerated a major seed cultivation...
Feb 07, 2023 09:00 am ET
Nearly Three Out of Four Colorado Smokers Want to Quit and Now Have a New Option That “Helps You Smoke Less”  
A new survey of 500 Colorado adults who smoke assessed the state of cigarettes in Colorado and found 74 percent were interested in quitting, and 87 percent see cutting back as a pivotal step in that process. The survey was conducted by Wakefield...
Jan 24, 2023 09:20 am ET
22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced the acquisition of privately held RX...
Jan 23, 2023 09:20 am ET
22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced filing of a U.S. Drug Master File (DMF) to the...
Jan 18, 2023 09:25 am ET
22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown
Two of the Largest U.S. Convenience Store Distributors Will Support VLN® Rollout into New States and Regions
Jan 17, 2023 09:00 am ET
FDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers
Proposed Menthol Ban Could Leave 22nd Century's VLN® Menthol King as the Only Menthol Cigarette in the $26 Billion U.S. Menthol Market
Dec 13, 2022 09:25 am ET
22nd Century Group (XXII) Comments on the Advancement of New Zealand's National Reduced Nicotine Content Law
Buffalo, New York--(Newsfile Corp. - December 13, 2022) -  22nd Century Group, Inc. (NASDAQ: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today commented on the advancement of a proposed New Zealand law designed to reduce the harms of smoking.
Dec 08, 2022 01:00 pm ET
22nd Century Group Provides Update on Grass Valley Facility
Customer shipments continue uninterrupted, expects to resume production within weeks
Nov 21, 2022 04:10 pm ET
22nd Century Group Provides Update on Incident at Grass Valley Facility
Established backup plans implemented to ensure continuous customer delivery
Nov 16, 2022 09:25 am ET
22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands
GVB Biopharma, a 22nd Century Group company (Nasdaq: XXII), today announced that it has opened a new, strategically-located distribution facility in the Netherlands to support its growing business in Europe, the Middle East, and Africa (EMEA). The...
Nov 15, 2022 09:25 am ET
22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company’s GVB Biopharma...
Nov 14, 2022 08:19 am ET
22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company will be...
Nov 08, 2022 06:00 am ET
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today reported results for the third quarter...
Nov 07, 2022 09:43 am ET
New Study Again Shows 22nd Century’s Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, highlighted a recent study that found switching...
Oct 27, 2022 09:15 am ET
22nd Century Group (Nasdaq: XXII) to Announce Third Quarter 2022 Results on November 8, 2022
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, will release third quarter 2022 financial...
Oct 26, 2022 09:25 am ET
22nd Century Group (Nasdaq: XXII) to Expand VLN® Sales in Three Additional States: Arizona, Utah and New Mexico
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company has further...
Oct 19, 2022 09:31 am ET
Thinking about buying stock in Liberty Energy, Carnival Corp, American Airlines, X4 Pharmaceuticals, or 22nd Century Group?
NEW YORK, Oct. 19, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LBRT, CCL, AAL, XFOR, and XXII.
Oct 18, 2022 09:20 am ET
22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that James A. Mish, chief...
Oct 14, 2022 08:58 am ET
Thinking about buying stock in Imara, Nutanix, Azul, 22nd Century Group, or Altimmune?
NEW YORK, Oct. 14, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IMRA, NTNX, AZUL, XXII, and ALT.
Oct 06, 2022 04:05 pm ET
22nd Century Group (Nasdaq: XXII) to Participate in the Dawson James Small Cap Growth Conference on October 12
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, announced today that James A. Mish, Chief...
Oct 06, 2022 09:30 am ET
First Cigarette Authorized by FDA to “Help You Smoke Less” Now Available Across Colorado
There’s a revolutionary new option available for the more than 680,000 adult smokers in Colorado — many of whom are trying to cut back or quit. VLN® brand cigarettes are the first and only combustible tobacco cigarettes to receive a Modified Risk...
Oct 03, 2022 09:25 am ET
22nd Century Group (Nasdaq: XXII) Expands VLN® Distributor Network with the Addition of Specialty Distributor Creager Mercantile
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company has added...
Sep 20, 2022 09:25 am ET
22nd Century Group (Nasdaq: XXII) Partners With Eagle Rock Distributing Company to Place VLN® in Thousands of Retail Locations Across Colorado
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that starting in September the...
Sep 13, 2022 09:30 am ET
22nd Century Group’s (Nasdaq: XXII) VLN® Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden’s Cancer Moonshot Initiative
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that it is engaged to power...
Sep 12, 2022 04:05 pm ET
22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced the appointment of Lucie S....
Sep 07, 2022 04:45 pm ET
22nd Century Group (Nasdaq: XXII) Announces Management Updates and Departure of Chief Operating Officer
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced changes in its management team...
Sep 07, 2022 09:00 am ET
22nd Century Group (Nasdaq: XXII) Launches VLN® Reduced Nicotine Content Cigarettes in Colorado with Circle K, Smoker Friendly and New Distribution Points
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that in September the Company...
Aug 24, 2022 09:27 am ET
22nd Century Group (Nasdaq: XXII) VLN® Reduced Nicotine Content Cigarettes Awarded Best New Product by Convenience Store News
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that VLN® King and VLN®...
Aug 22, 2022 09:30 am ET
22nd Century Group (Nasdaq: XXII) to Ring the Nasdaq Stock Market Closing Bell
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that it will ring the...
Aug 09, 2022 06:00 am ET
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today reported results for the second...
Jul 27, 2022 07:00 am ET
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2022 Results on August 9, 2022
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, will host a live webcast on Tuesday,...
Jul 21, 2022 10:00 am ET
22nd Century Group (Nasdaq: XXII) Strengthens Balance Sheet to Accelerate the Expansion of VLN Launch
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, announced that it has entered into...
Jul 21, 2022 09:00 am ET
22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules
22nd Century Group, Inc. (Nasdaq: XXII), leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that it has entered into...
Jun 22, 2022 09:25 am ET
22nd Century Group (Nasdaq: XXII) Supports Federal Proposal to Require Less Nicotine in All U.S. Cigarettes
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, is now selling the first and only 95%...
Jun 16, 2022 08:30 am ET
22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company), dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced the appointment of R. Hugh...
May 27, 2022 09:25 am ET
22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced that James A. Mish, Chief...
May 23, 2022 09:25 am ET
22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced John J. Miller will...
May 18, 2022 04:30 pm ET
22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced that it has begun...
May 13, 2022 09:16 am ET
22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced the acquisition of privately...
May 05, 2022 06:00 am ET
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today reported results for the first...
Apr 29, 2022 09:30 am ET
22nd Century Group (Nasdaq: XXII) Expects VLN® Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDA’s Proposed Ban on Menthol Cigarettes
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced its support of FDA’s...
Apr 28, 2022 09:30 am ET
22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced that the Company has...
Apr 27, 2022 09:25 am ET
22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced that James A. Mish,...
Apr 14, 2022 08:00 am ET
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, will host a live webcast on Thursday,...
Apr 13, 2022 08:00 am ET
First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland
The first and only combustible tobacco cigarette containing minimal to non-addictive levels of nicotine and authorized by the U.S. Food and Drug Administration (FDA) to help adult smokers smoke less is now available through a national pilot...
Apr 11, 2022 09:25 am ET
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced the appointment of Dr....
Mar 28, 2022 09:28 am ET
FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing
22nd Century Group, Inc. (Nasdaq: XXII), today announced that it has received notification from the Office of the Illinois Attorney General’s Tobacco Enforcement Bureau that its VLN® cigarettes will be listed in the Illinois Directory of...
Mar 09, 2022 09:30 am ET
22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced that James A. Mish,...
Mar 01, 2022 06:00 am ET
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2021
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today reported results for the fourth...
Feb 28, 2022 10:05 am ET
22nd Century Group Announces South Korea as First VLN® International Market
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced the $1.6 billion1...
Feb 25, 2022 09:51 am ET
22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in Combustible Cigarettes
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, congratulates Dr. Robert Califf on...
Feb 23, 2022 08:00 am ET
22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today, together with its...
Feb 10, 2022 11:30 am ET
22nd Century Secures USDA Organic Certification for Needle Rock Farms
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that is has received...
Feb 03, 2022 09:20 am ET
22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, will host a live webcast on Tuesday,...
Feb 01, 2022 12:30 pm ET
22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced its continued support...
Jan 26, 2022 11:00 am ET
22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced production of the...
Jan 21, 2022 08:00 am ET
22nd Century Group Appoints James A. Mish to Its Board of Directors
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced the appointment of...
Jan 18, 2022 09:55 am ET
Thinking about buying stock in Brickell Biotech, Zynga, 22nd Century Group, Nikola Corp, or Marathon Oil?
NEW YORK, Jan. 18, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BBI, ZNGA, XXII, NKLA, and MRO.
Jan 18, 2022 08:00 am ET
22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less
On December 23, 2021 the FDA announced an historic landmark decision in the fight against smoking when it authorized VLN® King and VLN® Menthol King from 22nd Century Group, Inc. (Nasdaq: XXII) as the first and only reduced nicotine content (RNC)...
Jan 03, 2022 02:23 pm ET
22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that Company...
Dec 27, 2021 09:45 am ET
Thinking about buying stock in Camber Energy, Carnival Corp, Biofrontera, 22nd Century Group, or SeaChange International?
NEW YORK, Dec. 27, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CEI, CCL, BFRI, XXII, and SEAC.
Dec 23, 2021 10:59 pm ET
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that the U.S. Food...
Dec 23, 2021 11:46 am ET
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that the U.S. Food...
Dec 23, 2021 09:45 am ET
Thinking about buying stock in Allakos, 22nd Century Group, Osmotica Pharmaceuticals, Banco Santander SA, or Opko Health?
NEW YORK, Dec. 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ALLK, XXII, OSMT, SAN, and OPK.
Dec 14, 2021 03:05 pm ET
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
Licensing deal set to assist in the advancement of research and development for cannabinoid biosynthesis
Dec 14, 2021 03:05 pm ET
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
Licensing deal set to assist in the advancement of research and development for cannabinoid biosynthesis
Dec 10, 2021 09:20 am ET
22nd Century Ready to Provide Full Commercial Support to New Zealand’s Plan to Reduce Nicotine Content of All Cigarettes
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through plant science, announced today that it is fully engaged and...
Nov 19, 2021 08:30 am ET
22nd Century Group Announces CFO Transition
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that Richard...
Nov 15, 2021 09:20 am ET
22nd Century Group Applauds Califf Nomination as FDA Commissioner
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through plant science, announced today that it strongly supports...
Nov 11, 2021 09:20 am ET
22nd Century to Participate in Cowen and Roth Capital Investor Conferences in November 2021
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through plant science, today announced that the Company will...
Nov 04, 2021 06:00 am ET
22nd Century Group Reports Business Highlights and Financial Results for the Third Quarter 2021
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through plant science, today reported results for the third quarter...
Oct 20, 2021 09:20 am ET
22nd Century Group to Host Webcast to Provide Business Update and Discuss Third Quarter 2021 Results
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science, will host a live webcast on Thursday,...
Oct 13, 2021 04:00 pm ET
22nd Century Group VP of Regulatory Science to Participate in FDLI Panel in Response to Recent FDA Action on Comprehensive Plan and Reduced Nicotine Mandate
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and health and wellness through plant science, announced today that the Company’s Vice President of...
Oct 01, 2021 09:20 am ET
22nd Century to Participate in the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on October 7
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology and intellectual property company focused on improving health and wellness through plant science, today announced that the Company will participate in the upcoming...
Sep 27, 2021 04:30 pm ET
22nd Century to Participate in September and October 2021 Investor Conferences
22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology and intellectual property company focused on improving health and wellness through plant science, today announced that the Company will participate in the following...
Aug 30, 2021 09:20 am ET
22nd Century Group Enters Global Specialty Hops Market
22nd Century Group, Inc. (Nasdaq: XXII), a leading plant biotechnology and intellectual property company focused on improving health and wellness through plant science, today announced entry into the global specialty hops market, its third and...
Aug 19, 2021 09:20 am ET
22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors
22nd Century Group, Inc. (Nasdaq: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced the appointment of Anthony Johnson to its Board of...
Aug 17, 2021 09:20 am ET
22nd Century to Present at SNN Network Investor Conference on August 19
22nd Century Group, Inc. (Nasdaq: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that its Chief Executive Officer, James A. Mish, is...
Aug 16, 2021 09:20 am ET
22nd Century Group to Ring Nasdaq Closing Bell Today, August 16
22nd Century Group, Inc. (Nasdaq: XXII) (formerly NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that it will ring the...
Aug 05, 2021 04:15 pm ET
22nd Century Group to Begin Trading on Nasdaq on August 16, 2021
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that its common stock has been approved for...
Aug 05, 2021 06:00 am ET
22nd Century Group Reports Business Highlights and Financial Results for the Second Quarter 2021
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today reported results for the second quarter ended June 30, 2021,...
Jul 22, 2021 09:25 am ET
22nd Century Group Secures New Contract Manufacturing Agreements, Expands Distribution Network and Manufacturing Capabilities Ahead of VLN® Launch
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that it has secured a substantial new agreement...
Jul 19, 2021 09:25 am ET
22nd Century Group to Host Webcast to Provide Business Update and Discuss Second Quarter 2021 Results
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, will host a live webcast on Thursday, August 5, 2021, at 10:00 AM...
Jul 14, 2021 09:25 am ET
22nd Century Group Adds Strategic Partnerships With Sawatch Agriculture and Folium Botanical for Next-Generation Commercial Hemp/Cannabis Plant Breeding and Commercial Scale-Up
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that it has added strategic partnerships with...
Jul 01, 2021 09:17 am ET
22nd Century Announces Restructuring of Panacea Investment, Expansion of Cannabis Franchise Capabilities
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced it has signed a definitive agreement to restructure...
Jun 25, 2021 09:25 am ET
22nd Century Group Provides Business Update from CEO Detailing Company Progress Over Past Year and Future Initiatives
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today released an update letter to its shareholders from CEO James...
Jun 10, 2021 07:00 am ET
Four Cannabis Stocks for the Summer of 2021
Cannabis stocks have staged a rousing return in recent weeks after a quiet first half of 2021. Sales are on the rise this year as revenue and profits for many cannabis companies have increased significantly. During the global COVID-19 pandemic...
Jun 09, 2021 04:30 pm ET
22nd Century Announces Closing of $40 Million Common Stock Registered Direct Offering
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that it closed the previously announced sale of 10...
Jun 09, 2021 01:35 pm ET
Reduced Nicotine Tobacco and Cannabinoid Innovator 22nd Century Group to Be Added to Russell 2000®, Russell 3000®, and Russell Global Indexes
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, is pleased to announce that it will be added to the Russell 2000®,...
Jun 07, 2021 10:42 am ET
22nd Century Advances Initiatives to Strengthen and Maximize Revenue Opportunities in Hemp/Cannabis Franchise
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced new initiatives to strengthen and maximize revenue...
Jun 07, 2021 09:25 am ET
22nd Century Announces $40 Million Common Stock Registered Direct Offering
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that it has entered into a definitive agreement...
May 24, 2021 09:06 am ET
22nd Century to Participate in May and June 2021 Investor Conferences
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that the Company will participate in the following...
May 18, 2021 10:06 am ET
22nd Century VP of Regulatory Science to Present on Health Disparities Caused by Cigarette Addiction at FDLI Annual Conference
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that the Company’s Vice President of Regulatory...
May 06, 2021 06:00 am ET
22nd Century Group Reports Business Highlights and Financial Results for the First Quarter 2021
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that the Company filed its 2021 First Quarter...
May 05, 2021 10:06 am ET
22nd Century Group Installs State-of-the-Art Nicotine Testing Equipment to Enhance VLN® Production
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that it is advancing and expanding capabilities in...
May 04, 2021 09:20 am ET
22nd Century Group and KeyGene Extend and Expand Plant Research Partnership
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it has reached an agreement to extend...
Apr 30, 2021 11:05 am ET
22nd Century Group Welcomes Ban on Menthol Cigarettes and Anticipates Further Standards as FDA Commissioner Reports Nicotine Cap on Combustibles “Still on the Table”
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, applauds the U.S. Food and Drug Administration (FDA) for...
Apr 29, 2021 06:50 am ET
Congresswoman Gwen Moore Adds Voice to Groundswell of Support for Reducing Nicotine in Cigarettes, Encourages HHS Secretary Becerra to Take Action to Save Lives and End Health Disparities
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, applauds Congresswoman Gwen Moore (D-WI-04) for...
Apr 26, 2021 10:06 am ET
22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it has fulfilled an order...
Apr 22, 2021 10:35 am ET
22nd Century Group to Host Webcast to Discuss First Quarter 2021 Results
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco and hemp/cannabis research, will host a live audio webcast on Thursday, May 6,...
Apr 21, 2021 10:35 am ET
22nd Century Group Issues Annual Letter to Shareholders
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company has issued its...
Apr 20, 2021 04:00 pm ET
22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S.
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very-low nicotine content tobacco, and hemp/cannabis research, reports that it is fully prepared to partner with...
Apr 15, 2021 05:56 pm ET
22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it is fully prepared to...
Apr 08, 2021 10:06 am ET
22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company’s Vice President...
Apr 01, 2021 10:06 am ET
Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation Would Be Game-Changing for 22nd Century
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it continues to be confident...
Mar 19, 2021 01:00 pm ET
Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco Industry
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today congratulated Xavier Becerra as the new Secretary...
Mar 12, 2021 10:00 am ET
22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced that it has received an additional $3.7...
Mar 11, 2021 07:00 am ET
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company filed its Annual...
Mar 05, 2021 09:15 am ET
22nd Century Group to Participate in Investor Conferences in March 2021
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced that members of its management team will...
Mar 04, 2021 09:15 am ET
22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced that it has received net proceeds of $8.1...
Mar 03, 2021 09:00 am ET
22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive Hemp/Cannabis Plant Lines and Intellectual Property
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it has secured an exclusive...
Feb 25, 2021 07:30 am ET
22nd Century Group to Host Webcast to Discuss Fourth Quarter and Full-Year 2020 Results
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, will host a live audio webcast on Thursday, March 11,...
Feb 24, 2021 10:00 am ET
22nd Century Group Provides Business Update Letter from CEO
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today provided a business update letter from...
Feb 10, 2021 10:00 am ET
22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable Traits
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it has developed and launched a new,...
Jan 28, 2021 10:00 am ET
22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville District
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company is moving its...
Jan 26, 2021 12:00 pm ET
The Buffalo News Op-ed: 22nd Century CEO Urges FDA to Proceed with Plan to Limit Nicotine Levels in Cigarettes
22nd Century Group, Inc., a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Buffalo News, the largest newspaper in Western...
Jan 19, 2021 07:30 am ET
Federal Court Dismisses Securities Class Action Lawsuit Against 22nd Century Group
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today the dismissal with prejudice of...
Jan 11, 2021 12:00 pm ET
22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company’s Reduced Nicotine Content Cigarettes
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company will...
Dec 17, 2020 10:10 am ET
22nd Century Group Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Controlling Genes Responsible for Production of CBD, THC, and Other Valuable Cannabinoids
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it was granted a new U.S. patent...
Dec 15, 2020 07:41 am ET
Thinking about buying stock in Anavex Life Sciences, Veru Inc, vTv Therapeutics, BioCardia, or 22nd Century Group?
NEW YORK, Dec. 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVXL, VERU, VTVT, BCDA, and XXII.
Dec 11, 2020 07:30 am ET
Thinking about buying stock in Walt Disney, vTv Therapeutics, 22nd Century Group, Lexicon Pharmaceuticals, or Ardelyx?
NEW YORK, Dec. 11, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DIS, VTVT, XXII, LXRX, and ARDX.
Dec 08, 2020 10:00 am ET
22nd Century Receives Order for 3.6 Million New SPECTRUM® Variable Nicotine Cigarettes for U.S. Government-Supported Research
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, announced today that the U.S. Food and Drug Administration (FDA) in coordination with the National Institute on...
Dec 04, 2020 10:00 am ET
22nd Century Group to Present at 13th Annual LD Micro Main Event Conference
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it will be presenting at the...
Nov 24, 2020 11:00 am ET
22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy Article
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that Morning Consult, a global...
Nov 20, 2020 08:31 am ET
Thinking about buying stock in Sorrento Therapeutics, Blink Charging, AMC Entertainment, 22nd Century Group, or Sunworks?
NEW YORK, Nov. 20, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SRNE, BLNK, AMC, XXII, and SUNW.
Nov 19, 2020 07:30 am ET
Thinking about buying stock in Aptevo Therapeutics, Electrameccanica Vehicles, AstraZeneca, Corcept Therapeutics, or 22nd Century Group?
NEW YORK, Nov. 19, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APVO, SOLO, AZN, CORT, and XXII.
Nov 18, 2020 10:00 am ET
22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that Chief Executive Officer,...
Nov 16, 2020 09:45 am ET
22nd Century Group to Present at the Virtual Fall Investor Summit on November 17
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company will present and...
Nov 05, 2020 07:00 am ET
22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company filed its 2020...
Oct 22, 2020 10:00 am ET
22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&A
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, life science company driven by next generation biotechnology, will host a live audio webcast on Thursday, November 5, 2020 at 8:00 a.m. Eastern Standard Time to discuss its 2020...
Oct 19, 2020 10:00 am ET
22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine Products Regulation and Policy Conference
22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, life science company driven by next generation biotechnology, announced today that Mitchell R. Zeller, director of the Center for Tobacco Products (CTP) at the U.S. Food and...
Oct 14, 2020 01:00 pm ET
22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tobacco Plants
22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based, life science company driven by next generation biotechnology, today announced it was granted a new U.S. patent related to the reduction of...
Sep 24, 2020 04:05 pm ET
22nd Century Group Provides Strategy Update Letter from CEO
22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based, life science company driven by next generation biotechnology, today provided a strategy update letter from Chief Executive Officer, James A....
Sep 17, 2020 04:05 pm ET
22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors
22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based, life science company driven by next generation plant biotechnology, today announced the appointment of Michael Koganov, Sc.D., Ph.D., to its...
Aug 31, 2020 05:00 pm ET
(LD Micro) 360 Companies Set to Present - this Week
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.